Curated industry list

Overvalued Stocks in Biotechnology on NYSE

Explore Overvalued Stocks in Biotechnology on NYSE. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Armata Pharmaceuticals Inc (ARMP)
Fair Value-23.4% Downside Overvalued Analyst280.4% Upside Market Cap172.9 M P/E-0.6x Yield0.0% HealthWeak
  NYSE Featured in Overvalued Stocks
Protalix Biotherapeutics Inc (PLX)
Analyst344.4% Upside Market Cap198.2 M P/E13.0x Yield0.0% HealthGreat
  NYSE Featured in Overvalued Stocks High-Beta Stocks
Arcus Biosciences Inc (RCUS)
Fair Value-5.9% Downside Fair Analyst34.0% Upside Market Cap3.644 B P/E-8.0x Yield0.0% HealthWeak
  NYSE Featured in Overvalued Stocks
Explore listed stocks on NYSE with company information and fair value data.